Quote this publication Share Print

BUCCOLAM

-
Opinions on drugs - Posted on Mar 19 2013

Reason for request

Inclusion on the list of medicines refundable by National Health Insurance and approved for hospital use.

-


Clinical Benefit

Substantial

The actual benefit of the proprietary medicinal products is substantial.


Clinical Added Value

minor

BUCCOLAM offers a level IV improvement in actual benefit in the management of prolonged acute convulsive seizures in children and adolescents suffering from epilepsy in view of its buccal administration and presentation in ready-to-use syringe form.


Contact Us

Évaluation des médicaments

See also